Inhibition of HIV-1 reverse transcriptase by RNA aptamers in Escherichia coli

RNA

Volumn 9, Issue 9, 2003, Pages 1029-1033

  Nickens, David G ^a   Patterson, James T ^a   Burke, Donald H ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Aptamer; Bioassay; HIV 1 reverse transcriptase; RNA protein interactions; SELEX

Indexed keywords

APTAMER; DNA; DNA POLYMERASE; RNA; RNA DIRECTED DNA POLYMERASE;

ARTICLE; BACTERIUM MUTANT; BIOASSAY; DNA SEQUENCE; ENZYME ASSAY; ENZYME INHIBITION; ESCHERICHIA COLI; GENE MUTATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN RNA BINDING;

ESCHERICHIA COLI; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; RNA; TEMPERATURE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0041331498     PISSN: 13558382     EISSN: None     Source Type: Journal    
DOI: 10.1261/rna.5550103     Document Type: Article

References (24)

1. Adachi, A., Gendelman, H.E., Koenig, S., Folks, T., Willey, R., Rabson, A., and Martin, M.A. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59: 284-291.
2. Andreola, M.L., Pileur, F., Calmels, C., Ventura, M., Tarrago-Litvak, L., Toulmé, J.J., and Litvak, S. 2001. DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity. Biochemistry 40: 10087-10094.
3. Burke, D.H. and Nickens, D.G. 2002. Expressing RNA aptamers inside cells to reveal proteome and ribonome function. Briefings in Functional Genomics and Proteomics 1: 169-188.
4. Burke, D.H., Scates, L., Andrews, K., and Gold, L. 1996. Bent pseudoknots and novel RNA inhibitors of type 1 human immunodeficiency virus (HIV-1) reverse transcriptase. J. Mol. Biol. 264: 650-666.
5. Chaloin, L., Lehmann, M.J., Sczakiel, G., and Restle, T. 2002. Endogenous expression of a high-affinity pseudoknot RNA aptamer supresses replication of HIV-1. Nucleic Acids Res. 30: 4001-4008.
6. Fisher, T.S., Joshi, P., and Prasad, V.R. 2002. Mutations that confer resistance to template-analog inhibitors of human immunodeficiency virus (HIV) type 1 reverse transcriptase lead to severe defects in HIV replication. J. Virol. 76: 4068-4072.
7. Gibbs, J.S., Regier, D.A., and Desrosiers, R.C. 1994. Construction and in vitro properties of HIV-1 mutants with deletions in "nonessential genes." AIDS Res. Human Retroviruses 10: 343-347.
8. Hizi, A., McGill, C., and Hughes, S.H. 1988. Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants. Proc. Natl. Acad. Sci. 85: 1218-1222.
9. Joshi, P. and Prasad, V.R. 2002. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment). J. Virol 76: 6545-6557.
10. Kensch, O., Connolly, B.A., Steinhoff, H., McGregor, A., Goody, R.S., and Restle, T. 2000. HIV-1 reverse transcriptase-pseudoknot RNA aptamer interaction has a binding affinity in the low picomolar range coupled with high specificity. J. Biol Chem. 275: 18271-18278.
11. Kim, B. 1997. Genetic selection in Escherichia coli for active human immunodeficiency virus reverse transcriptase mutants. Methods Comp. Methods Enzymol. 12:318-324.
12. Kim, B. and Loeb, L.A. 1995. Human immunodeficiency virus reverse transcriptase substitutes for DNA polymerase I in Escherichia coli. Proc. Natl. Acad. Sci. 92: 684-688.
13. Kim, B., Hathaway, T.R., and Loeb, L.A. 1996. Human immunodeficiency virus reverse transcriptase: Functional mutants obtained by random mutagenesis coupled with genetic selection in Escherichia coli. J. Biol. Chem. 271: 4872-4878.
14. Kubitschek, H.E. and Friske, J.A. 1986. Determination of bacterial cell volume with a coulter counter. J. Bacteriol. 168: 1466-1467.
15. Lanzer, M. and Bujard, H. 1988. Promoters largely determine the efficiency of repressor action. Proc. Natl. Acad. Sci. 85: 8973-8977.
16. Nahvi, A., Sudarsan, N., Ebert, M.S., Zou, X., Brown, K.L., and Breaker, R.R. 2002. Genetic control by a metabolite binding mRNA. Chem. Biol. 9: 1043-1049.
17. Schneider, D.J., Feigon, J., Hostomsky, Z., and Gold, L. 1995. High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus. Biochemistry 34: 9599-9610.
18. Sweasy, J. and Loeb, L. 1992. Mammalian DNA polymerase b can substitute for DNA polymerase I during DNA replication in Escherichia coli. J. Biol. Chem. 267: 1407-1412.
19. Takeshita, S., Sato, M., Toba, M., Masahashi, W., and Hashimoto-Gotoh, T. 1987. High-copy-number and low-copy-number plasmid vectors for lacZa-complementation and chloramphenicol- or kanamycin-resistance selection. Gene 61: 63-74.
20. Tuerk, C., MacDougal, S., and Gold, L. 1992. RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase. Proc. Natl. Acad. Sci. 89: 6988-6992.
21. Werstuck, G. and Green, M.R. 1998. Controlling gene expression in living cells through small molecule-RNA interactions. Science 282: 296-298.
22. Winkler, W., Nahvi, A., and Breaker, R.R. 2002a. Thiamine derivatives bind messenger RNAs directly to regulate bacterial gene expression. Nature 419: 952-956.
23. Winkler, W.C., Cohen-Chalamish, S., and Breaker, R.R. 2002b. An mRNA structure that controls gene expression by binding FMN. Proc. Natl. Acad. Sci. 99: 15908-15913.
24. Witkin, E.M.V. and Roegner-Maniscalco, V. 1992. Overproduction of DnaE protein (a subunit of DNA polymerase III) restores viability in a conditionally inviable Escherichia coli strain deficient in DNA polymerase I. J. Bacteriol. 174: 4166-4168.